National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Johannes A Langendijk; Frank J P Hoebers; Martin A de Jong; Patricia Doornaert; Chris H J Terhaard; Roel J H M Steenbakkers; Olga Hamming-Vrieze; Jeroen B van de Kamer; Wilko F A R Verbakel; Fatma Keskin-Cambay; Johannes B Reitsma; Arjen van der Schaaf; Liesbeth J Boersma; Ewoud Schuit

doi:10.14338/IJPT-20-00089.1

National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Johannes A Langendijk^*, Frank J P Hoebers, Martin A de Jong, Patricia Doornaert, Chris H J Terhaard, Roel J H M Steenbakkers, Olga Hamming-Vrieze, Jeroen B van de Kamer, Wilko F A R Verbakel, Fatma Keskin-Cambay, Johannes B Reitsma, Arjen van der Schaaf, Liesbeth J Boersma, Ewoud Schuit

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

43 Citations (Scopus)

80 Downloads (Pure)

Abstract

In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

Original language	English
Pages (from-to)	354-365
Number of pages	12
Journal	International journal of particle therapy
Volume	8
Issue number	1
DOIs	https://doi.org/10.14338/IJPT-20-00089.1
Publication status	Published - 2021

Access to Document

10.14338/IJPT-20-00089.1Licence: CC BY

National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer Final publisher's version, 1.05 MBLicence: CC BY

Handle.net

Persistent link

Cite this

Langendijk, J. A., Hoebers, F. J. P., de Jong, M. A., Doornaert, P., Terhaard, C. H. J., Steenbakkers, R. J. H. M., Hamming-Vrieze, O., van de Kamer, J. B., Verbakel, W. F. A. R., Keskin-Cambay, F., Reitsma, J. B., van der Schaaf, A., Boersma, L. J., & Schuit, E. (2021). National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer. International journal of particle therapy, 8(1), 354-365. https://doi.org/10.14338/IJPT-20-00089.1

@article{eb2c59e29f214fc6b78fb7c62354fedb,

title = "National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer",

abstract = "In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.",

author = "Langendijk, {Johannes A} and Hoebers, {Frank J P} and {de Jong}, {Martin A} and Patricia Doornaert and Terhaard, {Chris H J} and Steenbakkers, {Roel J H M} and Olga Hamming-Vrieze and {van de Kamer}, {Jeroen B} and Verbakel, {Wilko F A R} and Fatma Keskin-Cambay and Reitsma, {Johannes B} and {van der Schaaf}, Arjen and Boersma, {Liesbeth J} and Ewoud Schuit",

year = "2021",

doi = "10.14338/IJPT-20-00089.1",

language = "English",

volume = "8",

pages = "354--365",

journal = "International journal of particle therapy",

issn = "2331-5180",

publisher = "INT JOURNAL PARTICLE THERAPY",

number = "1",

}

Langendijk, JA, Hoebers, FJP, de Jong, MA, Doornaert, P, Terhaard, CHJ, Steenbakkers, RJHM, Hamming-Vrieze, O, van de Kamer, JB, Verbakel, WFAR, Keskin-Cambay, F, Reitsma, JB, van der Schaaf, A, Boersma, LJ & Schuit, E 2021, 'National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer', International journal of particle therapy, vol. 8, no. 1, pp. 354-365. https://doi.org/10.14338/IJPT-20-00089.1

TY - JOUR

T1 - National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

AU - Langendijk, Johannes A

AU - Hoebers, Frank J P

AU - de Jong, Martin A

AU - Doornaert, Patricia

AU - Terhaard, Chris H J

AU - Steenbakkers, Roel J H M

AU - Hamming-Vrieze, Olga

AU - van de Kamer, Jeroen B

AU - Verbakel, Wilko F A R

AU - Keskin-Cambay, Fatma

AU - Reitsma, Johannes B

AU - van der Schaaf, Arjen

AU - Boersma, Liesbeth J

AU - Schuit, Ewoud

PY - 2021

Y1 - 2021

N2 - In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

AB - In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

U2 - 10.14338/IJPT-20-00089.1

DO - 10.14338/IJPT-20-00089.1

M3 - Article

C2 - 34285961

SN - 2331-5180

VL - 8

SP - 354

EP - 365

JO - International journal of particle therapy

JF - International journal of particle therapy

IS - 1

ER -

National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Abstract

Access to Document

Handle.net

Fingerprint

Cite this